FDA Commissioner Scott Gottlieb vows to commit to market review of Essure

Read more

Zydus partners Medicure to launch its NDA product, ZYPITAMAG

Read more

Perrigo receives final approval from FDA for OTC equivalent of Mucinex DM

Read more

Veloxis submits sNDA to FDA seeking new indication for ENVARSUS XR

Read more

Ligand signs license agreement with Roivant Sciences

Read more

Biohaven enrolls first patient in Phase 3 Clinical Trial to assess Rimegepant Zydis ODT to treat Migraine

Read more

Apexigen and Pediatric Brain Tumor Consortium collaborate to evaluate APX005M in Brain tumor children

Read more

Citius Pharmaceuticals conveys progress in Hemorroid Treatment Program

Read more

Introducing the 2nd Annual HPAPI Conference this May 2018

Read more

Forendo Pharma appoints David Colpman as Non-executive Director to its board of directors

Read more